title: Analysis of current treatments used in clinical practice in a pediatric summer camp population for children with inflammatory bowel disease.
abstract: BACKGROUND
  Many treatment options exist for children with inflammatory bowel disease (IBD), yet the lack of clinical guidelines for management has lead to great variation in care. The purpose of this project was to evaluate current treatment modalities in children from the Northeast US who applied to the 2010 session of Camp Oasis, a Crohn's and Colitis Foundation of America (CCFA)-sponsored camp for children ages 8-17 with medically stable IBD.
  
  
  METHODS
  Patient demographics, medical history, and current medications were entered into the camp database. The subjects were divided into two groups; Crohn's disease (CD) or ulcerative colitis/indeterminate colitis (UC/IC). In all, 164 applicants were included, 121 (74%) with CD and 43 (26%) with UC/IC.
  
  
  RESULTS
  There were no significant differences between the two groups with respect to median age at the time of camp, median age at diagnosis, or median length of illness. Of the 121 applicants with CD, 13 (10.7%) were on an antibiotic, 56 (46.3%) were on a 5-aminosalicylate (5-ASA), 10 (8.3%) were on corticosteroids, 57 (47.1%) were on immunomodulators, and 44 (36.4%) were on a biologic agent. Six (5%) were on both an immunomodulator and a biologic agent. Of the 43 subjects with UC/IC, 27 (62.7%) were on a 5-ASA, two (4.7%) were on corticosteroids, 13 (30.2%) were on an immunomodulator, and four (9.3%) were on a biologic agent. The groups were similar with regard to surgery (20.7% for CD and 18.6% for UC/IC).
  
  
  CONCLUSIONS
  Identifying current treatment patterns may serve to highlight variations in care among this pediatric IBD population.
authors: Mount Sinai Medical Center, New York, New York 10029, USA.
authors: Danya
authors: D
authors: Rosen
authors: Kathy-Hoffstadter-Thal
authors: Ruijin
authors: R
authors: Bao
authors: Juli
authors: J
authors: Tomaino
authors: Clare
authors: C
authors: Ceballos
authors: Gary J M
authors: GJ
authors: Russell
authors: Keith J
authors: KJ
authors: Benkov
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D019804:Mesalamine / Q000627:therapeutic use*; D010818:Practice Patterns, Physicians'; D011379:Prognosis
chemical_list: D000305:Adrenal Cortex Hormones; D007155:Immunologic Factors; D019804:Mesalamine